Preoperative medical treatment in Cushing's syndrome. Frequency of use and its impact on postoperative assessment. Data from ERCUSYN.

Valassi, E; Franz, H; Brue, T; Feelders, R; Netea-Maier, R; Tsagarakis, S; Webb, S; Yaneva, M; Reincke, M; Droste, M; Komerdus, I; Maiter, D; Kastelan, D; Chanson, P; Pfeifer, M; Strasburger, C; Toth, M; Chabre, O; Krsek, M; Montañana, C; Bolanowski, M; Santos, A; Trainer, Peter J; Wass, J; Tabarin, A

Affiliation

Endocrinology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Issue Date

2018-02-12

Metadata

Show full item record

Abstract

Surgery is the definitive treatment of Cushing's syndrome (CS) but medications may also be used as a first-line therapy. Whether preoperative medical treatment (PMT) affects postoperative outcome remains controversial.

Citation

Preoperative medical treatment in Cushing's syndrome. Frequency of use and its impact on postoperative assessment. Data from ERCUSYN. 2018, Eur J Endocrinol

Journal

European Journal of Endocrinology

URI

http://hdl.handle.net/10541/620852

DOI

10.1530/EJE-17-0997

PubMed ID

29440375

Type

Article

Language

ISSN

1479-683X

Collections

All Christie Publications